Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome
Cells · 2026
DOI: 10.3390/cells15191768 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Gabriel Burdman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Brain, Organoids, Nervous System Diseases. Die Arbeit nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute of Health (NIH), NIDA NIH HHS.
Abstract (Originalsprache)
Neurological disorders are the leading cause of overall disease and disability worldwide, affecting more than 3.4 billion people globally and over 180 million Americans. Yet there are no curative treatments available for any of the cardinal neurological diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) and Huntington’s disease (HD). Many compounds that demonstrate excellent activity in preclinical models fail in clinical trials. The most compelling reason for this failure is attributed to inherent limitations of rodent models that fail to replicate complex human biology. The transformation of patient-derived somatic cells into induced pluripotent stem cells (iPSCs) that can become functional human neurons is an emerging technology that is expected to revolutionize medical treatments and personal medicine. Here, we review the available evidence for the efficacy of iPSC-derived neurons, organoids, assembloids and organ-on-chip in models of AD, PD, ALS-FTD and HD. We focus on how these human-relevant iPSC-derived brain cells are crucial for understanding neurological disease pathogenesis and accelerating drug discovery. We also discuss the current limitations of this technology and how alternative models such as induced neurons (iNs) are generated by directly reprogramming fibroblasts that preserve age-associated epigenetic signatures and may serve as better models for neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
- College of Arts, Sciences and Education, Florida International University, Miami, FL 33199, USA.
ORCID-Profile: Arti Vashist
Förderung
- NIA NIH HHS
- National Institute of Health (NIH)
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Burdman, G., Hanna, M., Arias, A. Y., Vashist, A., & Lakshmana, M. K. (2026). Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome. Cells. https://doi.org/10.3390/cells15191768
Vancouver
Burdman G, Hanna M, Arias AY, Vashist A, Lakshmana MK. Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome. Cells. 2026. doi:10.3390/cells15191768
BibTeX
@article{Burdman2026,
author = {Burdman, Gabriel and Hanna, Marco and Arias, Adriana Yndart and Vashist, Arti and Lakshmana, Madepalli K},
title = {Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15191768}
}
EUVIMED